Holen Sie sich die Stockscreener-App
18.79
2.18%
0.40
Handel nachbörslich:
18.79
Schlusskurs vom Vortag:
$18.39
Offen:
$18.39
24-Stunden-Volumen:
951.87K
Relative Volume:
0.95
Marktkapitalisierung:
$1.46B
Einnahmen:
$1.64B
Nettoeinkommen (Verlust:
$-495.80M
KGV:
-2.9341
EPS:
-6.404
Netto-Cashflow:
$-45.25M
1W Leistung:
+4.10%
1M Leistung:
+9.95%
6M Leistung:
+38.37%
1J Leistung:
+42.67%
1-Tages-Spanne:
$18.32
$18.86
1-Wochen-Bereich:
$17.01
$18.86
52-Wochen-Spanne:
$8.70
$18.92
Integra Lifesciences Holdings Corp Stock (IART) Company Profile
Firmenname
Integra Lifesciences Holdings Corp
Sektor
Branche
Telefon
(609) 275-0500
Adresse
1100 CAMPUS ROAD, PRINCETON, NJ
Compare IART vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IART
Integra Lifesciences Holdings Corp
|
18.79 | 1.46B | 1.64B | -495.80M | -45.25M | -6.404 |
ABT
Abbott Laboratories
|
93.93 | 163.61B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
329.78 | 126.42B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.87 | 107.36B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.77 | 66.54B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
92.21 | 53.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Integra Lifesciences Holdings Corp Stock (IART) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-15 | Herabstufung | Argus | Buy → Hold |
| 2025-03-31 | Hochstufung | Argus | Hold → Buy |
| 2024-12-02 | Eingeleitet | Morgan Stanley | Underweight |
| 2024-10-07 | Hochstufung | BTIG Research | Sell → Neutral |
| 2024-07-30 | Herabstufung | BTIG Research | Neutral → Sell |
| 2024-07-30 | Herabstufung | Citigroup | Neutral → Sell |
| 2024-05-07 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2024-05-07 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-04-03 | Hochstufung | Citigroup | Sell → Neutral |
| 2023-12-05 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-11-14 | Eingeleitet | CL King | Buy |
| 2023-08-24 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2023-07-12 | Hochstufung | Jefferies | Hold → Buy |
| 2023-06-08 | Herabstufung | Argus | Buy → Hold |
| 2023-05-24 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-05-23 | Herabstufung | Citigroup | Neutral → Sell |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-07-25 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-04-13 | Herabstufung | Truist | Buy → Hold |
| 2021-12-17 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2021-09-15 | Herabstufung | BTIG Research | Buy → Neutral |
| 2020-10-08 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-05-27 | Eingeleitet | Citigroup | Neutral |
| 2020-04-03 | Eingeleitet | SunTrust | Buy |
| 2020-01-07 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2019-01-03 | Eingeleitet | SunTrust | Buy |
| 2018-11-28 | Eingeleitet | UBS | Neutral |
| 2018-08-07 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-07-26 | Hochstufung | BTIG Research | Neutral → Buy |
| 2018-07-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2018-01-05 | Fortgesetzt | Cantor Fitzgerald | Neutral |
| 2018-01-02 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-11-09 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-10-30 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2017-10-27 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2017-06-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-05-02 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-01-13 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-01-06 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2016-12-12 | Eingeleitet | UBS | Buy |
Alle ansehen
Integra Lifesciences Holdings Corp Aktie (IART) Neueste Nachrichten
IART Initiated Coverage by BMO Capital -- Rating Set to Market P - GuruFocus
BMO initiates Integra LifeSciences stock at Market Perform By Investing.com - Investing.com Nigeria
BMO initiates Integra LifeSciences stock at Market Perform - Investing.com
Form 4 Integra LifeSciences Holdings For: 6 July By Investing.com - Investing.com Canada
Integra Lifesciences (NASDAQ: IART) SVP uses 937 shares for tax withholding - Stock Titan
Integra LifeSciences (IART) grants EVP 5,590 RSUs vesting over 3 years - Stock Titan
Integra LifeSciences (IART) EVP awarded 11,180 RSUs in new equity grant - Stock Titan
IART CFO Lea Daniels Knight uses 5,226 shares to satisfy tax obligations - Stock Titan
Integra Lifesciences Holdings Corp (IART) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Integra LifeSciences Appoints Topaz Kirlew Chief Regulatory Officer - Finviz
Integra LifeSciences Names Topaz Kirlew Chief Regulatory Officer - citybiz
Integra LifeSciences taps interim regulatory chief for global role - Stock Titan
Integra Lifesciences Holdings Corp (IART) Shares Fall 4.2% -- Wh - GuruFocus
Is Integra LifeSciences’ New Commercial Structure Recasting Its Execution Story for Investors in IART? - Yahoo Finance
Integra LifeSciences Hits New 52-Week High at $18.49 - MarketsMojo
Integra LifeSciences Holdings stock hits 52-week high at $18.30 - Investing.com
Zacks.com featured highlights TPG Mortgage Investment Trust, Silvercorp and Integra LifeSciences - Yahoo Finance
Surgical Equipment & ConsumablesSpecialty Stocks Q1 Results: Benchmarking Integra LifeSciences (NASDAQ:IART) - Yahoo Finance
Integra Lifesciences Holdings Corporation Announces Executive Changes - marketscreener.com
Integra LifeSciences Announces Key Executive Appointments - The Manila Times
Integra LifeSciences reshuffles commercial leadership in medtech push - Stock Titan
Integra LifeSciences: New Beginning (NASDAQ:IART) - Seeking Alpha
Integra LifeSciences StockSunday background on risks and outlook - AD HOC NEWS
Integra LifeSciences Opens with 5.47% Gain, Marking Significant Gap Up - MarketsMojo
symbol__ Stock Quote Price and Forecast - CNN
Integra LifeSciences (IART) Upgraded to Buy with Positive Outloo - GuruFocus
Argus upgrades Integra LifeSciences stock rating on turnaround - Investing.com
Argus upgrades Integra LifeSciences stock rating on turnaround By Investing.com - Investing.com Canada
Why is Integra LifeSciences stock gaining today? By Investing.com - Investing.com South Africa
Why is Integra LifeSciences stock gaining today? - Investing.com
Integra Lifesciences Holdings Corp - TradingKey
Integra Lifesciences Holdings Corp (IART) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Integra Lifesciences Holdings Corp (IART) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Integra Lifesciences Holdings Corp (IART) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Integra Lifesciences Holdings Corp (IART) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Integra Lifesciences Holdings Corp (IART) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Integra Lifesciences Holdings Corp (IART) Valuation: PE, PB & Fair Value Analysis - TradingKey
Integra Lifesciences Holdings Corp (IART) Institutional Confidence - TradingKey
Integra Lifesciences Holdings Corp (IART) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Integra LifeSciences Hits New 52-Week High at $18.18 - MarketsMojo
Integra LifeSciences Holdings Corporation (IART) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
Integra LifeSciences to Present at the 2026 Truist Securities MedTech Conference - GlobeNewswire
Live webcast of Integra Truist MedTech talk set for June 16 - Stock Titan
Integra LifeSciences Hits New 52-Week High at $17.79 - MarketsMojo
Integra LifeSciences Hits New 52-Week High at $18.02 - MarketsMojo
Integra LifeSciences stock hits 52-week high at 17.84 USD - Investing.com
Integra LifeSciences (IART) EPS Beat and Conference Push: What Does It Reveal About Management’s Conviction? - Yahoo Finance
3 Reasons to Avoid IART and 1 Stock to Buy Instead - Yahoo Finance
Why Is Integra (IART) Up 15% Since Last Earnings Report? - Yahoo Finance
Integra (IART) EVP awarded RSUs and stock options in new grant - Stock Titan
Integra (IART) CEO receives new RSU and stock option grants - Stock Titan
Finanzdaten der Integra Lifesciences Holdings Corp-Aktie (IART)
Umsatz
Nettogewinn
Free Cashflow
ENV
Integra Lifesciences Holdings Corp-Aktie (IART) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL |
Mar 10 '26 |
Option Exercise |
0.00 |
1,216 |
0 |
23,152 |
| Poul Mojdeh | President & CEO |
Jan 06 '26 |
Option Exercise |
0.00 |
1,390 |
0 |
1,390 |
| GRAVES JEFFREY A | Director |
Nov 05 '25 |
Buy |
11.35 |
9,000 |
102,150 |
41,086 |
| Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL |
Oct 12 '25 |
Option Exercise |
0.00 |
11,965 |
0 |
25,217 |
2.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):